Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Extraventricular neurocytoma (EVN), a variant of central neurocytoma, is a rare neuronal neoplasm, composed of round cells with neuronal differentiation, which is located outside of the ventricular system, usually within the spinal cord or cerebral hemispheres and that manifests with headache, nausea, vomiting, complex partial seizures or focal neurological deficits. In some cases it may exhibit atypical features consistent with aggressive clinical behavior.
Biomarker and diagnostic research for extraventricular neurocytoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE4. Research is primarily industry-sponsored.
13 publications have been identified in PubMed for extraventricular neurocytoma. Research spans Case Report / Case Series (46%), Review / Meta-Analysis (15%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 46% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 2:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
2 |
15% |
Laboratory research | 2 | 15% |
Other research | 1 | 8% |
Testing and diagnosis research | 1 | 8% |
New treatment approaches | 1 | 8% |
Métais A (2026). [PMID: 42163841](https://pubmed.ncbi.nlm.nih.gov/42163841/). *Neuropathol Appl Neurobiol*. [Basic Science / Preclinical]
Wang Y (2026). [PMID: 42215018](https://pubmed.ncbi.nlm.nih.gov/42215018/). *J Neuropathol Exp Neurol*. [Basic Science / Preclinical]
Mezzacappa FM (2026). [PMID: 35015431](https://pubmed.ncbi.nlm.nih.gov/35015431/). *Unknown Journal*. [Review / Meta-Analysis]
Valerio J (2025). [PMID: 40677455](https://pubmed.ncbi.nlm.nih.gov/40677455/). *Cureus*. [Case Report / Case Series]
Ravi S (2025). [PMID: 40824702](https://pubmed.ncbi.nlm.nih.gov/40824702/). *Indian J Pathol Microbiol*. [Case Report / Case Series]
Feldmann JFL (2025). [PMID: 40575153](https://pubmed.ncbi.nlm.nih.gov/40575153/). *Front Oncol*. [Case Report / Case Series]
Wang H (2025). [PMID: 40176273](https://pubmed.ncbi.nlm.nih.gov/40176273/). *Pediatr Blood Cancer*. [Other]
Kweh BTS (2024). [PMID: 38000064](https://pubmed.ncbi.nlm.nih.gov/38000064/). *J Neurosurg*. [Review / Meta-Analysis]
Chen MF (2024). [PMID: 38922339](https://pubmed.ncbi.nlm.nih.gov/38922339/). *Clin Cancer Res*. [Gene Therapy / Novel Therapeutics]
Matsunaga S (2024). [PMID: 39708128](https://pubmed.ncbi.nlm.nih.gov/39708128/). *Childs Nerv Syst*. [Case Report / Case Series]